Ipilimumab prolongs survival in stage III melanoma: The EORTC 18071 trial
1. Patients with resected stage III melanoma treated with adjuvant ipilimumab lived significantly longer than those who received placebo. 2....
Shaidah attended York University for her undergraduate degree and majored in Health Sciences with a specialization in cellular physiology. She then completed her Master of Science degree in Nutritional Sciences at the University of Toronto in 2011. After working in the research field for two years, she started studying medicine at the University of Toronto. In 2017, she completed her training and started working at Queen's University as a Resident in General Surgery.
1. Patients with resected stage III melanoma treated with adjuvant ipilimumab lived significantly longer than those who received placebo. 2....
1. The two-year risk of developing cardiovascular death, nonfatal myocardial infarction (MI) or stroke was approximately 25% less in patients...
1. In the 1970s, observational data suggested a direct link between serum cholesterol levels and the risk of coronary heart...
1. Rates of HIV transmission were significantly lower for two combined antiretroviral therapies (ART) compared to single drug zidovudine prophylaxis....
1. No significant difference was observed in 28-day mean SOFA score or overall mortality in patients who received levosimendan vs....
1. Presence of a familial hypercholesterolemia mutation without elevated total cholesterol levels is insufficient to make diagnosis of familial hypercholesterolemia....
1. There was no mortality benefit associated with receiving long-term oxygen supplementation in patients with stable chronic obstructive pulmonary disease...
1. The rate of prostate-cancer-specific mortality was nonsignificantly different for active surveillance, radical prostatectomy, and external beam radiation therapy over...
1. After advent of mammography, detection rate of large tumors decreases while detection of smaller tumors increases. 2. The decreased...
1. Patients undergoing prostatectomy for prostate cancer had significantly worse self-reported urinary and sexual function compared to radiotherapy and active...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.